Thermo Fisher Sci…
USUSDThermo Fisher Scientific Inc (US:TMO) — Industrial Machinery/Components. Брой борси, на които се търгуват акциите на компанията: 3. На тази страница — цена и график, дивиденти, най-големи акционери и история на броя на акциите.
За компанията
- Уебсайт
- thermofisher.com
- Сектор
- Industrials · Industrial Machinery/Components
- Централа
- Waltham, United States
- Изпълнителен директор
- Marc N. Casper
- Служители
- 67 816
- Основана
- 2006
- Акции в обращение
- 369.75 млн към 2026-06-27
- Свободно търгуеми акции
- 368.82 млн
- Пазарна капитализация
- 241.26 млрд USD
- Инсайдери
- 0.13%
- Институционални инвеститори
- 94.08%
- Отрасъл (SIC)
- Measuring & Controlling Devices, NEC
- Правна форма
- XTIQ
- ISIN
- US8835561023
- LEI
- HCHV7422L5HDJZCRFL38
- Коефициент на изплащане
- 9.5%
- FCF
- 7.32 млрд USD9%
- Дълг
- 42.3 млрд USD5.2 г. FCF
- Дивидентна история
- 14 г.
- Печалба, FCF и изплатени дивиденти — за 12-те месеца до 27.06.2026 (последният отчет на компанията).
Описание
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Дивиденти
Thermo Fisher Scientific Inc (TMO) изплаща дивиденти на тримесечие. През последните 12 месеца на акция са изплатени 1.84 USD (плащания: 4). Това е около 0.28% от текущата цена на акцията. Според историята на плащанията следващата екс-дивидентна дата се очаква около 15.12.2026. Години непрекъснати дивиденти: 14.
| Екс-дата | Изплащане | Сума | % | Вид | Тикер |
|---|---|---|---|---|---|
| 2026-09-15 | 2026-10-15 | 0.4700 USD | 0.1/0.3 % | тримесечно | US:TMO |
| 2026-06-15 | 2026-07-15 | 0.4700 USD | 0.1/0.3 % | тримесечно | US:TMO |
| 2026-03-13 | 2026-04-15 | 0.4700 USD | 0.1/0.3 % | тримесечно | US:TMO |
| 2025-12-15 | 2026-01-15 | 0.4300 USD | 0.1/0.3 % | тримесечно | US:TMO |
| 2025-09-15 | 2025-10-15 | 0.4300 USD | 0.1/0.3 % | тримесечно | US:TMO |
| 2025-06-13 | 2025-07-15 | 0.4300 USD | 0.1/≈0.3 % | тримесечно | US:TMO |
| 2025-03-14 | 2025-04-15 | 0.4300 USD | 0.1/≈0.3 % | тримесечно | US:TMO |
| 2024-12-13 | 2025-01-15 | 0.3900 USD | 0.1/≈0.2 % | тримесечно | US:TMO |
Новини тази седмица
Никакви новини през последната седмица. Последни новини: 28.09.2026.
Най-големи притежатели
| Притежател | Дял | Акции | Дата на доклада |
|---|---|---|---|
| Blackrock Inc. | 8.36% | 30.92 млн | 2026-06-30 |
| Vanguard Capital Managem… | 6.57% | 24.28 млн | 2026-06-30 |
| State Street Corporation | 4.55% | 16.83 млн | 2026-06-30 |
| FMR, LLC | 3.81% | 14.08 млн | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.19% | 11.8 млн | 2026-06-30 |
| Morgan Stanley | 2.91% | 10.76 млн | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.6% | 9.63 млн | 2026-06-30 |
| JPMORGAN CHASE & CO | 2.3% | 8.5 млн | 2026-06-30 |
| Geode Capital Management… | 2.27% | 8.38 млн | 2026-06-30 |
| Franklin Resources, Inc. | 1.97% | 7.27 млн | 2026-06-30 |
| Vanguard Portfolio Manag… | 1.68% | 6.23 млн | 2026-06-30 |
| Capital World Investors | 1.68% | 6.2 млн | 2026-06-30 |
| iShares Trust-iShares Co… | 1.34% | 4.95 млн | 2026-08-31 |
| Fidelity Concord Street… | 1.3% | 4.81 млн | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.23% | 4.55 млн | 2026-08-31 |
| Fidelity Contrafund | 1.06% | 3.91 млн | 2026-07-31 |
| VANGUARD INDEX FUNDS-Van… | 0.96% | 3.54 млн | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.72% | 2.67 млн | 2026-08-31 |
| Dodge & Cox Funds-Dodge… | 0.56% | 2.06 млн | 2026-06-30 |
| VANGUARD INSTITUTIONAL I… | 0.55% | 2.02 млн | 2026-06-30 |
| CASPER MARC N (Chief Exe… | ≈0.04% | 140 225 | 2026-08-24 |
| LAGARDE MICHEL (Chief Op… | ≈0.02% | 86 347 | 2026-02-25 |
| SPERLING SCOTT M (Direct… | ≈0.02% | 69 479 | 2026-05-20 |
| WILLIAMSON STEPHEN (Chie… | ≈0.01% | 46 095 | 2026-02-25 |
| PETTITI GIANLUCA (Presid… | ≈0.01% | 23 216 | 2026-08-31 |
| SHAFER MICHAEL D (Office… | ≈0.01% | 20 994 | 2026-08-11 |
| LOWERY FREDERICK M. (Off… | ≈0% | 17 133 | 2026-02-25 |
| CHAI NELSON J (Director) | ≈0% | 15 316 | 2026-05-20 |
| BRITT LISA P (Officer) | ≈0% | 14 784 | 2026-08-19 |
| BOXER MICHAEL A (General… | ≈0% | 10 815 | 2025-03-10 |
